Near-Patient Molecular Solutions Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Near-Patient Molecular Solutions Market Report 2026

Name: Near-Patient Molecular Solutions Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types), By Technology (Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based), By End-User (Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Near-Patient Molecular Solutions Market Overview

• Near-Patient Molecular Solutions market size has reached to $4.54 billion in 2025

• Expected to grow to $7.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Surge In Demand For Home-based Point-Of-Care Devices Fueling The Growth Of The Market Due To Increasing Consumer Autonomy And Convenience

• Market Trend: Integration Of Advanced Molecular Amplification Technologies To Enhance Near-Patient Diagnostic Performance

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Near-Patient Molecular Solutions Market?

Near-patient molecular solutions are diagnostic tests that use molecular biology techniques, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) detection, and are performed at or very close to where the patient receives care. These tests analyze small biological samples on-site instead of sending them to a central laboratory, allowing rapid and accurate detection of pathogens or biomarkers using portable or simplified instruments. By delivering quick and reliable results in outpatient, emergency, or remote settings, they support timely treatment decisions and better health outcomes.

The main product types of near-patient molecular solutions include infectious disease testing kits, urinalysis testing kits, tumor or cancer markers, pregnancy and fertility, hematology testing kits, glucose monitoring kits, drugs-of-abuse testing kits, coagulation monitoring kits, cardiometabolic monitoring kits, and others. Infectious disease testing kits are diagnostic tools designed to rapidly detect and identify pathogens such as bacteria, viruses, or parasites in patient samples to aid in timely disease diagnosis and treatment. The different technologies involved are polymerase chain reaction (PCR)-based, genetic sequencing-based, hybridization-based, and are used for several end-users, including hospitals and clinics, ambulatory care centers, research laboratories, home care settings, and others.

Near-Patient Molecular Solutions Market Global Report 2026 Market Report bar graph

What Is The Near-Patient Molecular Solutions Market Size and Share 2026?

The near-patient molecular solutions market size has grown strongly in recent years. It will grow from $4.54 billion in 2025 to $4.99 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to expansion of molecular diagnostic techniques, demand for rapid test turnaround times, decentralization of laboratory services, growth in outpatient diagnostic settings, adoption of portable diagnostic instruments.

What Is The Near-Patient Molecular Solutions Market Growth Forecast?

The near-patient molecular solutions market size is expected to see strong growth in the next few years. It will grow to $7.17 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising demand for home and remote testing solutions, technological advancements in miniaturized molecular platforms, expansion of infectious disease surveillance, integration with digital health ecosystems. Major trends in the forecast period include increasing adoption of point-of-care molecular testing devices, rising demand for rapid infectious disease diagnostics, growing integration of portable PCR platforms, expansion of decentralized diagnostic infrastructure, enhanced focus on near-patient testing accuracy.

Book your 30 minutes free consultation with our research experts

Global Near-Patient Molecular Solutions Market Segmentation

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

What Is The Driver Of The Near-Patient Molecular Solutions Market?

Growing demand for home-based point-of-care devices is expected to propel the growth of the near patient molecular solutions market going forward. Home-based point-of-care devices are diagnostic testing systems that patients or non-laboratory users operate at or near their home, enabling sample collection, analysis, or result reading outside a conventional central laboratory setting and in or close to the place of care. The growing demand for home-based point-of-care devices is increasing due to the rising consumer preference for convenient, rapid, and accessible health monitoring outside traditional healthcare settings. Near-patient molecular solutions support the home-based point-of-care devices by providing accurate, rapid, and portable molecular diagnostics that can be reliably used outside traditional laboratory settings. For instance, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, reported in its 2023 COVID-19 testing update that there was one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Therefore, growing demand for home-based point-of-care devices is driving the growth of the near-patient molecular solutions industry.

Key Players In The Global Near-Patient Molecular Solutions Market

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Global Near-Patient Molecular Solutions Market Trends and Insights

Major companies operating in the near-patient molecular solutions market are focusing on incorporating technological advancements such as isothermal nucleic acid amplification to enhance testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is an advanced molecular diagnostic technology that amplifies target nucleic acid sequences at a constant temperature, eliminating the need for thermal cycling as in conventional polymerase chain reaction (PCR), thereby enabling rapid, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for the Cue COVID-19 Molecular Test, an isothermal amplification-based diagnostic device designed for at-home and point-of-care detection of SARS-CoV-2 RNA. The system features a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that guides users through testing and delivers molecular results in about 20 minutes. The Cue COVID-19 molecular test improves access to accurate molecular-level diagnostics, reduces turnaround time, and supports real-time health decision-making outside traditional laboratory environments.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Near-Patient Molecular Solutions Market?

In July 2024, Roche Holding AG, a Switzerland-based provider of in-vitro diagnostics and pharmaceutical solutions, acquired LumiraDx’s point-of-care (POC) technology business for $353.5 million. With this acquisition, Roche gains access to LumiraDx’s portable, multi-assay diagnostic platform, enhancing its decentralized and near-patient testing capabilities, broadening its presence in primary care and community-based settings, and improving delivery of rapid and reliable diagnostic results outside traditional laboratory environments. LumiraDx Group Limited is a UK-based provider of next-generation point-of-care diagnostics known for its compact instrument that integrates immunoassay, clinical chemistry, and emerging molecular testing capabilities in near-patient applications.

Regional Outlook

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market consists of sales of sample preparation devices, nucleic acid extraction kits, portable molecular analyzers, isothermal amplification kits, microfluidic cartridges, and multiplex detection panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Near-Patient Molecular Solutions Market Report 2026?

The near-patient molecular solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the near-patient molecular solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Near-Patient Molecular Solutions Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.99 billion
Revenue Forecast In 2035	$7.17 billion
Growth Rate	CAGR of 9.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Technology, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Near-Patient Molecular Solutions Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Near-Patient Molecular Solutions Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Near-Patient Molecular Solutions Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Near-Patient Molecular Solutions Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Point-Of-Care Molecular Testing Devices

4.2.2 Rising Demand For Rapid Infectious Disease Diagnostics

4.2.3 Growing Integration Of Portable Pcr Platforms

4.2.4 Expansion Of Decentralized Diagnostic Infrastructure

4.2.5 Enhanced Focus On Near-Patient Testing Accuracy

5. Near-Patient Molecular Solutions Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Ambulatory Care Centers

5.3 Diagnostic Laboratories

5.4 Home Healthcare Providers

5.5 Research Institutions

6. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Near-Patient Molecular Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Near-Patient Molecular Solutions Market Size, Comparisons And Growth Rate Analysis

7.3. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Near-Patient Molecular Solutions Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Near-Patient Molecular Solutions Market Segmentation

9.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

9.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

9.3. Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

9.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

9.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

9.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

9.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

9.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

9.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

9.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

9.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

9.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

10. Near-Patient Molecular Solutions Market Regional And Country Analysis

10.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Near-Patient Molecular Solutions Market

11.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Near-Patient Molecular Solutions Market

12.1. China Near-Patient Molecular Solutions Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Near-Patient Molecular Solutions Market

13.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Near-Patient Molecular Solutions Market

14.1. Japan Near-Patient Molecular Solutions Market Overview

14.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Near-Patient Molecular Solutions Market

15.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Near-Patient Molecular Solutions Market

16.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Near-Patient Molecular Solutions Market

17.1. South Korea Near-Patient Molecular Solutions Market Overview

17.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Near-Patient Molecular Solutions Market

18.1. Taiwan Near-Patient Molecular Solutions Market Overview

18.2. Taiwan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Near-Patient Molecular Solutions Market

19.1. South East Asia Near-Patient Molecular Solutions Market Overview

19.2. South East Asia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Near-Patient Molecular Solutions Market

20.1. Western Europe Near-Patient Molecular Solutions Market Overview

20.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Near-Patient Molecular Solutions Market

21.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Near-Patient Molecular Solutions Market

22.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Near-Patient Molecular Solutions Market

23.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Near-Patient Molecular Solutions Market

24.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Near-Patient Molecular Solutions Market

25.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Near-Patient Molecular Solutions Market

26.1. Eastern Europe Near-Patient Molecular Solutions Market Overview

26.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Near-Patient Molecular Solutions Market

27.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Near-Patient Molecular Solutions Market

28.1. North America Near-Patient Molecular Solutions Market Overview

28.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Near-Patient Molecular Solutions Market

29.1. USA Near-Patient Molecular Solutions Market Overview

29.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Near-Patient Molecular Solutions Market

30.1. Canada Near-Patient Molecular Solutions Market Overview

30.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Near-Patient Molecular Solutions Market

31.1. South America Near-Patient Molecular Solutions Market Overview

31.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Near-Patient Molecular Solutions Market

32.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Near-Patient Molecular Solutions Market

33.1. Middle East Near-Patient Molecular Solutions Market Overview

33.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Near-Patient Molecular Solutions Market

34.1. Africa Near-Patient Molecular Solutions Market Overview

34.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Near-Patient Molecular Solutions Market Regulatory and Investment Landscape

36. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles

36.1. Near-Patient Molecular Solutions Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Near-Patient Molecular Solutions Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Near-Patient Molecular Solutions Market Company Profiles

36.3.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Near-Patient Molecular Solutions Market Other Major And Innovative Companies

Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc

38. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market

40. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies

40.1 Near-Patient Molecular Solutions Market In 2030 - Countries Offering Most New Opportunities

40.2 Near-Patient Molecular Solutions Market In 2030 - Segments Offering Most New Opportunities

40.3 Near-Patient Molecular Solutions Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Near-Patient Molecular Solutions Market, Overview Of Key Products - Product Examples

Table 2: Global Near-Patient Molecular Solutions Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Near-Patient Molecular Solutions Market, Supply Chain Analysis

Table 4: Global Near-Patient Molecular Solutions Market, Major Raw Material Providers

Table 5: Global Near-Patient Molecular Solutions Market, Major Resource Providers

Table 6: Global Near-Patient Molecular Solutions Market, Major Manufacturers (Suppliers)

Table 7: Global Near-Patient Molecular Solutions Market, Major Distributors And Channel Partners

Table 8: Global Near-Patient Molecular Solutions Market, Key Technologies & Future Trends

Table 9: Global Near-Patient Molecular Solutions Market, Major Trends

Table 10: Global Near-Patient Molecular Solutions Market, Major End Users

Table 11: Global Near-Patient Molecular Solutions Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Near-Patient Molecular Solutions Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Near-Patient Molecular Solutions Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Near-Patient Molecular Solutions Market - TAM, US$ Billion, 2025

Table 15: Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: China, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: China, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: China, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: India, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: India, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: India, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Japan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Japan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Japan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Australia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Australia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Australia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South Korea, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: UK, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: UK, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: UK, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Germany, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Germany, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Germany, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: France, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: France, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: France, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Italy, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Italy, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Italy, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Spain, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Spain, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Spain, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: Russia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Russia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Russia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: North America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: North America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: North America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: USA, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: USA, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: USA, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Canada, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Canada, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Canada, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: South America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: South America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: South America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Brazil, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Middle East, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Africa, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 100: Africa, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 101: Africa, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 102: Global Near-Patient Molecular Solutions Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 103: Global Near-Patient Molecular Solutions Market - Company Scoring Matrix

Table 104: Bosch Healthcare Solutions GmbH Financial Performance

Table 105: Roche Holding AG Financial Performance

Table 106: Thermo Fisher Scientific Inc. Financial Performance

Table 107: Abbott Laboratories Financial Performance

Table 108: Danaher Corporation Financial Performance

Table 109: Global Near-Patient Molecular Solutions Market, Competitive Benchmarking (In USD Billions)

Table 110: Global Near-Patient Molecular Solutions Market, Competitive Dashboard

Table 111: Global Near-Patient Molecular Solutions Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 112: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 113: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 114: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Near-Patient Molecular Solutions Market, Overview Of Key Products - Product Examples

Figure 2: Global Near-Patient Molecular Solutions Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Near-Patient Molecular Solutions Market, Supply Chain Analysis

Figure 4: Global Near-Patient Molecular Solutions Market, Major Raw Material Providers

Figure 5: Global Near-Patient Molecular Solutions Market, Major Resource Providers

Figure 6: Global Near-Patient Molecular Solutions Market, Major Manufacturers (Suppliers)

Figure 7: Global Near-Patient Molecular Solutions Market, Major Distributors And Channel Partners

Figure 8: Global Near-Patient Molecular Solutions Market, Key Technologies & Future Trends

Figure 9: Global Near-Patient Molecular Solutions Market, Major Trends

Figure 10: Global Near-Patient Molecular Solutions Market, Major End Users

Figure 11: Global Near-Patient Molecular Solutions Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Near-Patient Molecular Solutions Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Near-Patient Molecular Solutions Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Near-Patient Molecular Solutions Market - TAM, US$ Billion, 2025

Figure 15: Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Asia-Pacific, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: China, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: China, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: China, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: India, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: India, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: India, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Japan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Japan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Japan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Australia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Australia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Australia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Indonesia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South Korea, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South Korea, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Taiwan, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: South East Asia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Western Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: UK, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: UK, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: UK, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Germany, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Germany, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Germany, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: France, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: France, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: France, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Italy, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Italy, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Italy, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Spain, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Spain, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Spain, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Eastern Europe, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: Russia, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Russia, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Russia, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: North America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: North America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: North America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: USA, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: USA, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: USA, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Canada, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Canada, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Canada, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: South America, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: South America, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: South America, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Brazil, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Brazil, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Middle East, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Middle East, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Africa, Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 100: Africa, Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 101: Africa, Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 102: Global Near-Patient Molecular Solutions Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 103: Global Near-Patient Molecular Solutions Market - Company Scoring Matrix

Figure 104: Bosch Healthcare Solutions GmbH Financial Performance

Figure 105: Roche Holding AG Financial Performance

Figure 106: Thermo Fisher Scientific Inc. Financial Performance

Figure 107: Abbott Laboratories Financial Performance

Figure 108: Danaher Corporation Financial Performance

Figure 109: Global Near-Patient Molecular Solutions Market, Competitive Benchmarking (In USD Billions)

Figure 110: Global Near-Patient Molecular Solutions Market, Competitive Dashboard

Figure 111: Global Near-Patient Molecular Solutions Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 112: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 113: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 114: Global, Near-Patient Molecular Solutions Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Non-Therapeutic Biomolecules Market Report 2026 - Global Outlook – By Trad Pharma (Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User (Research, Pharma, In Vitro Diag...

Clinical Chemistry Market Report 2026 - Global Outlook – By Product (Analyzers, Reagents And Consumables ), By Application (General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel...

Small Molecule Drug Discovery Market Report 2026 - Global Outlook – By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology...

Small Molecule Injectable Drugs Market Report 2026 - Global Outlook – By Drug Class (Small Molecule Antibiotics, Analgesics, Chemotherapy, Antivirals, Anticoagulant, Skeletal Muscle Relaxants, Anticonvulsants, Other Drug...

Small Molecule Active Pharmaceutical Ingredient Market Report 2026 - Global Outlook – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Card...

Molecular Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain react...

Drug Infusion Systems Market Report 2026 - Global Outlook – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Anal...

Frequently Asked Questions

How big is the Near-Patient Molecular Solutions Market?

The Near-Patient Molecular Solutions market was valued at $4.54 billion in 2025, increased to $4.99 billion in 2026, and is projected to reach $7.17 billion by 2030.

What is the Near-Patient Molecular Solutions market growth?

The global Near-Patient Molecular Solutions market is expected to grow at a CAGR of 9.5% from 2026 to 2035 to reach $7.17 billion by 2035.

Who are the key players in Near-Patient Molecular Solutions market?

Some Key Players in the Near-Patient Molecular Solutions market Include, Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc. .

What is the anticipated growth trend for the Near-Patient Molecular Solutions market?

Major trend in this market includes: Integration Of Advanced Molecular Amplification Technologies To Enhance Near-Patient Diagnostic Performance. For further insights on this market. request a sample here

Which region has the most growth potential in the Near-Patient Molecular Solutions market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.